Arpeggio Biosciences

📍 Boulder, United States🗓 Founded 2017👥 21 employees💰 Last funded Sep 2022
Biotechnology🌐 arpeggiobio.com
Website LinkedIn
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development. We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Arpeggio Biosciences?
Arpeggio Biosciences has 2 investors on record on gritt.io, 2 mid-stage.
When did Arpeggio Biosciences last raise funding?
The most recent investment in Arpeggio Biosciences recorded on gritt.io was in September 2022.
When was Arpeggio Biosciences founded?
Arpeggio Biosciences was founded in 2017.
What industry is Arpeggio Biosciences in?
Arpeggio Biosciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Arpeggio Biosciences based?
Arpeggio Biosciences is headquartered in Boulder, United States.